Revenue: The sum of all revenue fields included for a company's operating activities.
Bio-Rad Laboratories, Inc. (BIO.B) had Revenue of $693.20M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$693.20M |
$720.00M |
|
$348.00M |
|
$345.20M |
|
$812.10M |
|
$-118.90M |
|
$1.05B |
|
$929.20M |
|
$-100.30M |
|
$720.00M |
|
$720.00M |
|
$720.00M |
|
$-539.98M |
|
$-118.90M |
|
$-118.90M |
|
27.26M |
|
27.28M |
|
$26.61 |
|
$26.59 |
|
| Balance Sheet Financials | |
$2.91B |
|
$539.90M |
|
$7.67B |
|
$10.58B |
|
$517.00M |
|
$1.20B |
|
$2.61B |
|
$3.12B |
|
$7.45B |
|
$6.70B |
|
$7.45B |
|
26.99M |
|
| Cash Flow Statement Financials | |
$532.20M |
|
$-189.70M |
|
$-283.20M |
|
$489.80M |
|
$532.20M |
|
$42.40M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.62 |
|
-- |
|
-- |
|
0.14 |
|
0.16 |
|
49.80% |
|
-17.15% |
|
-17.15% |
|
-- |
|
134.04% |
|
103.87% |
|
$374.70M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.47 |
|
1.50 |
|
59.80 |
|
9.66% |
|
10.75% |
|
6.81% |
|
8.32% |
|
$276.16 |
|
$13.73 |
|
$19.51 |
|